x Acta Scientific | International Open Library | Open Access Journals Publishing Group

Acta Scientific Nutritional Health (ASNH)(ISSN: 2582-1423)

Research Article Volume 4 Issue 8

ACTA2 Mutations and Risk of Premature Myocardial Infarction

Fatemeh Hajibabaie1,1, Mohammad Hossein Modarressi3, Masoumeh Sadeghi4* and Laleh Shariati5,6*

1Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
2Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
3Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
5Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
6Department of Biomaterials, Nanotechnology and Tissue Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

*Corresponding Author: Masoumeh Sadeghi, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran and Laleh Shariati, Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences and Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

Received: July 07, 2020; Published: July 30, 2020

Reprints View PDF Related Articles

×

Abstract

Introduction: Premature myocardial infarction (MI) is characterized by high re-infarction rates, the occurrence of severe heart failure and therefore significant cardiovascular long-term mortality at a young age. Previous studies demonstrated that one of the most important risk factors in younger patients is family history and genetic factors. This research was launched to assess the association of ACTA2 genetic variations with premature MI.

Materials and Methods: Out of eighty unrelated patients with premature MI referred to health center, patients with autosomal dominant premature MI were included in the study. Exclusion criteria included hypercholesterolemia, hyperlipidemia, diabetes and smoking. Genomic DNA was extracted from the whole peripheral blood. Eight exons and intron/exon boundaries of the ACTA2 gene were amplified, and all the amplicons were subject to Sanger sequencing.

Results: According to the criteria, 16 patients were included in our research. No mutations were found in ACTA2 gene in our pro-bands.

Keywords: Premature Myocardial Infarction; ACTA2; Pathogenesis

×

References

  1. Benjamin EJ., et al. “Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association”. Circulation10 (2017): e146-e603.
  2. Hajibabaie F., et al. “MicroRNAs as the actors in the atherosclerosis scenario”. Journal of Physiology and Biochemistry (2019).
  3. Dai X., et al. “Genetics of coronary artery disease and myocardial infarction”. World Journal of Cardiology 1 (2016): 1-23.
  4. Zipes D., et al. “Braunwald Eugene Braunwald’s Heart Disease: A Text book of Cardiovascular Medicine”. Philadelphia (2005).
  5. Mohseni J., et al. “A Systematic Review on the Prevalence of Acute Myocardial Infarction in Iran”. Heart Views4 (2017): 125-32.
  6. Organization WH. World health statistics 2018: monitoring health for the SDGs, sustainable development goals (2018).
  7. Ayani S., et al. “Survey and classification of functional characteristics in neural network technique for the diagnosis of ischemic heart disease: A systematic review”. Journal of Isfahan Medical School 460 (2018): 1830-1839.
  8. Guo DC., et al. “Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease”. American Journal of Human Genetics 5 (2009): 617-627.
  9. Gabbiani G., et al. “Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin”. Proceedings of the National Academy of Sciences of the United States of America 1 (1981): 298-302.
  10. Milewicz DM., et al. “De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction”. American Journal of Medical Genetics10 (2010): 2437-2443.
  11. Zhu L., et al. “Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus”. Nature Genetics3 (2006): 343-349.
  12. Guo DC., et al. “Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections”. Nature Genetics12 (2007): 1488-1493.
  13. Dillon PF., et al. “Myosin phosphorylation and the cross-bridge cycle in arterial smooth muscle”. Science 4481 (1981): 495-497.
  14. Morisaki H., et al. “Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD)”. Human Mutation10 (2009): 1406-1411.
  15. Morisaki H., et al. “Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD)”. Human Mutation10 (2009): 1406-1411.
  16. Wang Q. “Molecular genetics of coronary artery disease”. Current Opinion on Cardiology3 (2005): 182-188.
  17. Hoffjan S., et al. “Three novel mutations in the ACTA2 gene in German patients with thoracic aortic aneurysms and dissections”. European Journal of Human Genetics 5 (2011): 520-524.
  18. Munot P., et al. “A novel distinctive cerebrovascular phenotype is associated with heterozygous Arg179 ACTA2 mutations”. Brain 2012 135 (2012): 2506-2514.
  19. Disabella E., et al. “Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2)”. Heart4 (2011): 321-326.
  20. Katz J., et al. “On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease”. Journal of Clinical Periodontology9 (2001): 865-868.
  21. Yokoyama Y., et al. “MicroRNAs as Potential Mediators for Cigarette Smoking Induced Atherosclerosis”. International Journal of Molecular Sciences 4 (2018).
  22. Low Wang CC., et al. “Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations”. Circulation24 (2016): 2459-2502.
  23. Hajibabaie F., et al. “MicroRNAs as the actors in the atherosclerosis scenario”. Journal of Physiology and Biochemistry1 (2020): 1-12.
  24. Huang Y., et al. “Biological functions of microRNAs: a review”. Journal of Physiology and Biochemistry 1 (2011): 129-139.
  25. Dong S., et al. “MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction”. Journal of Biological Chemistry 43 (2009): 29514-29525.
  26. Shan ZX., et al. “Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction”. Biochemical and Biophysical Research Communications4 (2009): 597-601.
  27. Zhou C., et al. “MicroRNA-208b Alleviates Post-Infarction Myocardial Fibrosis in a Rat Model by Inhibiting GATA4”. Medical Science Monitor 22 (2016): 1808-1816.
  28. Dosenko VE., et al. “Mature and immature microRNA ratios in cultured rat cardiomyocytes during anoxia-reoxygenation”. Experimental and Clinical Cardiology2 (2012): 84-87.
  29. Aavik E., et al. “Global DNA methylation analysis of human atherosclerotic plaques reveals extensive genomic hypomethylation and reactivation at imprinted locus 14q32 involving induction of a miRNA cluster”. European Heart Journal16 (2015): 993-1000.
  30. Sadatian A. “Major protests and treatment of heart disease”. Tehran: samat (2001).
  31. Yusuf S., et al. “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study”. Lancet9438 (2004): 937-952.
  32. Tortora G., et al. “Search for genetic factors in bicuspid aortic valve disease: ACTA2 mutations do not play a major role”. Interactive CardioVascular and Thoracic Surgery 5 (2017): 813-817.
×

Citation

Citation: Masoumeh Sadeghi, Laleh Shariati., et al. “ACTA2 Mutations and Risk of Premature Myocardial Infarction". Acta Scientific Nutritional Health 4.8 (2020): 60-66.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.316

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US





Creative Commons License Open Access by Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com

ff

Acta-Publications

ff

© 2021 Acta Scientific, All rights reserved.